Global Ranitidine Market Outlook 2017-2022

July 2017 | 98 pages | ID: G953FF96993EN
Gen Consulting Company

Abstracts

Ranitidine belongs to a class of medications, called H2–Blockers used for treatment of ulcers. Ranitidine blocks the action of histamine (acid) on stomach cells thus reducing stomach acid production. Ranitidine is useful in healing of stomach ulcers and reducing ulcer pain and has been effective in preventing ulcer recurrence when given in low doses for prolonged period of time. In doses higher than that used in ulcer treatment, Ranitidine HCl has been helpful in treating heartburn and in healing ulcer and inflammation of the throat resulting from the acid reflects. The product patent for Ranitidine HCl was held by GlaxoSmithkline (GSK) and was marketed under the brand name ‘Zantac’. The product patent for Ranitidine HCl held by GSK expired in 2002.

The report covers forecast and analysis for the ranitidine market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. The study includes drivers and restraints for the ranitidine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the ranitidine market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global ranitidine market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

Key Regions

• North America
• Europe
• Asia Pacific

Key Vendors

• Saraca Laboratories
• SMS Pharmaceuticals
• Orchev Pharma
• Neuland Laboratories
• Strides Arcolab
• Uquifa
• Haili
• BSLC
• Hansitong
• Zenji
• Homesun
• Qingyang Yaoye

Key Questions Answered in this Report

• What will the market size be in 2022?
• What are the key factors driving the global ranitidine market?
• What are the challenges to market growth?
• Who are the key players in the ranitidine market?
• What are the market opportunities and threats faced by the key players?

Contents

PART 1. EXCLUSIVE SUMMARY

PART 2. METHODOLOGY

2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

PART 3. INTRODUCTION

3.1 Product Overview
3.2 Applications of Ranitidine
3.3 Manufacturing Process
3.4 Raw Materials
3.5 Cost Analysis

PART 4. COMPETITIVE LANDSCAPE

4.1 Global Ranitidine Market, by Volume 2012-2017
  4.1.1 Overview
  4.1.2 Global Ranitidine Market, by Volume, by Company
  4.1.3 Top 3 Companies by Volume Share
4.2 Global Ranitidine Market, by Revenue 2012-2017
  4.2.1 Overview
  4.2.2 Global Ranitidine Market, by Revenue, by Company
  4.2.3 Top 3 Companies by Revenue Share

PART 5. MARKET DYNAMICS

5.1 Market Drivers
5.2 Challenges
5.3 Market Trends

PART 6. NORTH AMERICA

6.1 North American Ranitidine Market Size
6.2 by Country
  6.2.1 United States
  6.2.2 Canada

PART 7. EUROPE

7.1 European Ranitidine Market Size
7.2 by Country
  7.2.1 Germany
  7.2.2 UK
  7.2.3 France

PART 8. ASIA-PACIFIC

8.1 Asia-Pacific Ranitidine Market Size
8.2 by Country
  8.2.1 China
  8.2.2 Japan
  8.2.3 India

PART 9. RANITIDINE MARKET FORECAST

9.1 Global Ranitidine Market Size 2017-2022
9.2 Global Ranitidine Market by Region 2017-2022
  9.2.1 North America
  9.2.2 Europe
  9.2.3 Asia-Pacific

PART 10. COMPANY PROFILES

10.1 Saraca Laboratories
  10.1.1 Business Overview
  10.1.2 Products Offered
  10.1.3 Financials
10.2 SMS Pharmaceuticals
10.3 Orchev Pharma
10.4 Neuland Laboratories
10.5 Strides Arcolab
10.6 Uquifa
10.7 Haili
10.8 BSLC
10.9 Hansitong
10.10 Zenji
10.11 Homesun
10.12 Qingyang Yaoye

PART 11. APPENDIX

11.1 Abbreviations
11.2 Disclaimer